Download PDF
Thromb Haemost 1988; 59(03): 485-490
DOI: 10.1055/s-0038-1647520
Original Article
Schattauer GmbH Stuttgart

Plasma Collagen Cofactor Correlates with von Willebrand Factor Antigen and Ristocetin Cofactor but Not with Bleeding Time

Morio Aihara
1   The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
,
Asano Kimura
2   The Blood Transfusion Service, Hirosaki University School of Medicine, Hirosaki, Japan
,
Yoichi Chiba
3   The Hirosaki National Hospital, Hirosaki, Japan
,
Yutaka Yoshida
1   The First Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki, Japan
› Author Affiliations
Further Information

Publication History

Received 03 September 1987

Accepted after revision 19 February 1988

Publication Date:
29 June 2018 (online)

Also available at
  PDF Download Permissions and Reprints

Summary

Collagen cofactor (CCo), an activity of von Willebrand factor (vWF) which increases the rate of adhesion of human fixed washed platelets (FWP) to collagen, was measured in plasma from normal individuals and individuals with von Willebrand’s disease (vWD). CCo in vWD plasma was compared to vWF antigen (vWF:Ag), ristocetin cofactor (RCo), factor VIII (VIII) coagulant activity (VIII:C) and the quantitative bleeding time. There was close correlation between CCo and VIII:C (r = 0.909), vWF:Ag (r = 0.975), and RCo (r = 0.936). However, there was no correlation between CCo and the quantitative bleeding time. Plasma CCo in type IIA vWD was markedly lower than vWF: Ag and the ratio of CCo/vWF: Ag was 0.08, which was less than a mean value of 0.92 in type I vWD. CCo activity in normal plasma was completely inhibited by monoclonal antibody CLB-RAg 201, an antibody that inhibits the binding of vWF to collagen, suggesting that the binding of vWF to collagen is required for the expression of CCo. Furthermore, the partial inhibition of CCo by monoclonal antibody CLB-RAg 35 that inhibits the binding of vWF to platelet in the presence of ristocetin, suggests that CCo is partly mediated through platelet membrane glycoprotein Ib. Large multimers of vWF:Ag in normal plasma were preferentially absorbed by collagen. These studies demonstrate that CCo is another functional activity of vWF and the measurement of CCo may be useful for the detection of new variant forms of vWD.

Keywords

Platelt - von Willebrand factor - Collagen - Collagen cofactor - Platelet adhesion
 

  • References

  • 1 Counts RB, Paskell SL, Elgee SK. Disulfide bonds and the quaternary structure of factor VUI/von Willebrand factor. J Clin Invest 1978; 62: 702-709
    CrossrefPubMedSearch in Google Scholar
  • 2 Meyer D, Obert B, Pietu G, Lavergne JM, Zimmerman TS. Multimeric structure of factor VUI/von Willebrand factor in von Willebrand’s disease. J Lab Clin Med 1980; 95: 590-602
    PubMedSearch in Google Scholar
  • 3 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. J Clin Invest 1977; 60: 390-404
    CrossrefPubMedSearch in Google Scholar
  • 4 Santoro SA. Adsorption of von Willebrand factor/factor VIII by the genetically distinct interstitial collagens. Thromb Res 1981; 21: 689-93
    CrossrefPubMedSearch in Google Scholar
  • 5 Wagner DD, Urban-Pickering M, Marder VJ. Von Willebrand protein binds to extracellular matrices independently of collagen. Proc Natl Acad Sci USA 1984; 81: 471-475
    CrossrefPubMedSearch in Google Scholar
  • 6 Fauvel F, Grant HE, Legrand YJ, Souchon H, Tobelem G, Jackson DS, Caen JP. Interaction of blood platelets with a microfibrillar extract from adult bovine aorta. Requirement for von Willebrand factor. Proc Natl Acad Sci USA 1983; 80: 551-554
    CrossrefPubMedSearch in Google Scholar
  • 7 Sixma JJ, Sakariassen KS, Stel HV, Houdijk WP M, der Maur DW, Hamer RJ, de Groot PG, van Mourik JA. Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen J Clin Invest 1984; 74: 736-744
    CrossrefPubMedSearch in Google Scholar
  • 8 Aihara M, Cooper HA, Wagner RH. Platelet-collagen interaction. Increase in rate of adhesion of fixed washed platelets by factor VIII- related antigen Blood 1984; 63: 495-501
    PubMedSearch in Google Scholar
  • 9 Perret BA, Furlan M, Jeno P, Beck EA. Von Willebrand factor-dependent agglutination of washed fixed human platelets by insoluble collagen isolated from bovine aorta. J Lab Clin Med 1985; 107: 244-252
    PubMedSearch in Google Scholar
  • 10 Aihara M, Kimura A, Tanabe K, Momma T, Chiba Y, Yoshida Y. Acquired von Willebrand’s disease. Review of the literature and clinicopathological study in a case Hirosaki Med J 1984; 36: 50-63
    PubMedSearch in Google Scholar
  • 11 Aihara M, Takami H, Sawada Y, Morimoto S, Kariya K, Kudo I, Ueno K, Kimura A, Yoshida Y. Effect of fibronectin and von Willebrand factor on the adhesion of human fixed washed platelets to collagen immobilized beads. Thromb Res 1986; 44: 661-672
    CrossrefPubMedSearch in Google Scholar
  • 12 Laurell CB. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
    CrossrefPubMedSearch in Google Scholar
  • 13 Owen WG, Wagner RH. Antihemophilic factor. separation of an active fragment following dissociation by salts or detergents Thromb Diathes Haemorrh 1972; 27: 502-515
    PubMedSearch in Google Scholar
  • 14 Ruggeri ZM, Zimmerman TS. The complex multimeric composition of factor VIII/von Willebrand factor. Blood 1981; 57: 1140-1143
    PubMedSearch in Google Scholar
  • 15 Aihara M, Sawada Y, Ueno K, Morimoto S, Yoshida Y, de Serres M, Cooper HA, Wagner RH. Visualization of von Willebrand factor multimers by immunoenzymatic stain using avidin-biotin peroxidase complex. Thromb Haemostas 1986; 55: 263-267
    PubMedSearch in Google Scholar
  • 16 Cooper HA, Reisner FF, Hall M, Wagner RH. Effects of thrombin treatment on preparations of factor VIII and the Ca2+-dissociated small active fragment. J Clin Invest 1975; 56: 751-760
    CrossrefPubMedSearch in Google Scholar
  • 17 Binnie C, Wagner RH, Cooper HA, Hermans J. Parallel characterization of bovine von Willebrand protein (factor VIII-associated protein) by light scattering and SDS gel electrophoresis. Thromb Res 1986; 40: 523-532
    PubMedSearch in Google Scholar
  • 18 Sutor ET, Bowie EJ W, Thompson JH, Didisheim P, Mertins BF, Owen CA. Bleeding from standardized skin punctures. Automated technique for recording time, intensity, and pattern of bleeding Am J Clin Pathol 1971; 55: 541-550
    CrossrefPubMedSearch in Google Scholar
  • 19 Weiss HJ, Turitto VT, Baumgartner HR. Effect of shear rate on platelet interaction with subendothelium in citrated and native blood. I. Shear rate dependent decrease of adhesion in von Willebrand’s disease and the Bernard-Soulier syndrome. J Lab Clin Med 1978; 92: 750-764
    PubMedSearch in Google Scholar
  • 20 Bolhuis PA, Sakariassen KS, Sander HJ, Bouma BN, Sixma JJ. Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med 1981; 97: 568-576
    PubMedSearch in Google Scholar
  • 21 Madri JA, Dreyer B, Pitlick FA, Furthmayr H. The collagenous components of the subendothelium. Correlation of structure and function Lab Invest 1980; 43: 303-315
    PubMedSearch in Google Scholar
  • 22 de Groot PG, van Mourik JA, Sixma JJ. Primary binding site of von Willebrand factor in the subendothelium which mediates platelet adhesion is not collagen. Thromb Haemostas 1987; 58: 213 (Abstr)
    PubMedSearch in Google Scholar
  • 23 Mannucci PM, Lombardi R, Bader R, Vianello L, Federici AB, Solinas S, Mazzucconi MG, Mariani G. Heterogeneity of type I von Willebrand’s disease. Evidence for a subgroup with an abnormal von Willebrand factor Blood 1985; 66: 796-802
    PubMedSearch in Google Scholar
  • 24 Gralnick HR, Rick ME, McKeown LP, Williams SB, Parker RI, Maisonneuve P, Jenneau C, Sultan Y. Platelet von Willebrand factor. An important determinant of the bleeding time in type I von Willebrand’s disease Blood 1986; 68: 58-61
    PubMedSearch in Google Scholar
  • 25 Weiss HJ. Relation of von Willebrand factor to bleeding time. New Engl J Med 1974; 290: 420
    CrossrefPubMedSearch in Google Scholar
  • 26 Martin E, Marder VJ, Francis CW, Barlow GH. Structural studies on the functional heterogeneity of von Willebrand protein polymers. Blood 1981; 57: 313-323
    PubMedSearch in Google Scholar
  • 27 Houdijk WPM, Schiphorst ME, Sixma JJ. Identification of functional domains on von Willebrand factor by binding of tryptic fragments to collagen and to platelets in the presence of ristocetin. Blood 1986; 67: 1498-1503
    PubMedSearch in Google Scholar
  • 28 Pareti FI, Fujimura Y, Dent JA, Holland LZ, Zimmerman TS, Ruggeri ZM. Isolation and characterization of a collagen binding domain in human von Willebrand factor. J Biol Chem 1986; 261: 15310-15315
    CrossrefPubMedSearch in Google Scholar
  • 29 Fretto LJ, Fowler WE, McCaslin DR, Erickson HP, McKee PA. Substructure of human von Willebrand factor. Proteolysis by V8 and characterization of two functional domains J Biol Chem 1986; 261: 15678-15686
    PubMedSearch in Google Scholar
  • 30 Girma JP, Kalafatis M, Pietu G, Lauvergne JM, Chopek MW, Edgington TS, Meyer D. Mapping of distinct von Willebrand factor domains interacting with platelet GP Ib and GP IIb/IIIa and with collagen using monoclonal antibodies. Blood 1986; 67: 1356-1366
    PubMedSearch in Google Scholar
  • 31 Pareti FI, Niiya K, McPherson JM, Ruggeri ZM. Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. J Biol Chem 1987; 262: 13835-13841
    PubMedSearch in Google Scholar
  • 32 Bockenstedt P, Greenberg JM, Handin RI. Structural basis of von Willebrand factor binding to platelet glycoprotein Ib and collagen. Effects of disulfide reduction and limited proteolysis of polymeric von Willebrand factor J Clin Invest 1986; 77: 743-749
    CrossrefPubMedSearch in Google Scholar
  • 33 Roth GJ, Titani K, Hoyer LW, Hickey MJ. Localization of binding sites within human von Willebrand factor for monomeric type III collagen. Biochemistry 1986; 25: 8357-8361
    CrossrefPubMedSearch in Google Scholar
  • 34 Fujimura Y, Titani K, Holland LZ, Russell SR, Roberts JR, Elder JH, Ruggeri ZM, Zimmerman TS. Von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. J Biol Chem 1986; 261: 381-385
    PubMedSearch in Google Scholar
  • 35 Aihara M, Morimoto S, Sawada Y, Kimura A, Chiba Y, Yoshida Y. A role of platelet membrane components in the interaction of platelet-collagen-von Willebrand factor. Thromb Haemostas 1987; 58: 455 (Abstr)
    PubMedSearch in Google Scholar
  • 36 Brown JE, Bosak JO. An ELISA test for the binding of von Willebrand antigen to collagen. Thromb Res 1986; 43: 303-311
    CrossrefPubMedSearch in Google Scholar
  • 37 Duggan MJ, DiMichele DM, Christian MJ, Fink LM, Hathaway WE. Collagen-binding of von Willebrand factor antigen in the classification of von Willebrand’s disease. Am J Clin Pathol 1987; 88: 97-102
    CrossrefPubMedSearch in Google Scholar
  • 38 Aihara M, Kudo I, Ishigaki H, Ueno K, Sawada Y, Yoshida Y, Cooper HA, Wagner RH. Two affinity immunoelectrophoretic methods for studying collagen interaction with von Willebrand factor antigen. Tohoku J Exp Med 1987; 153: 169-177
    CrossrefPubMedSearch in Google Scholar